Found: 46
Select item for more details and to access through your institution.
ANCA-associated vasculitis with isolated splenomegaly as the initial organ presentation.
- Published in:
- Rheumatology Advances in Practice, 2024, v. 8, n. 2, p. 1, doi. 10.1093/rap/rkae045
- By:
- Publication type:
- Article
Clinical Outcomes of Second‐Line Chemotherapy in Patients with Previously Treated Advanced Thymic Carcinoma: A Retrospective Analysis of 191 Patients from the NEJ023 Study.
- Published in:
- Oncologist, 2020, v. 25, n. 4, p. e668, doi. 10.1634/theoncologist.2019-0593
- By:
- Publication type:
- Article
Successful Treatment with Lorlatinib after the Development of Alectinib-Induced Liver Damage in ALK-Positive Non-Small-Cell Lung Cancer: A Case Report.
- Published in:
- Case Reports in Oncology, 2021, v. 14, n. 1, p. 197, doi. 10.1159/000513624
- By:
- Publication type:
- Article
A phase I/II trial of weekly nab‐paclitaxel for pretreated non‐small‐cell lung cancer patients without epidermal growth factor receptor mutations and anaplastic lymphoma kinase rearrangement.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2019, v. 15, n. 4, p. 250, doi. 10.1111/ajco.13147
- By:
- Publication type:
- Article
Clinical characteristics of patients treated with immune checkpoint inhibitors in EGFR-mutant non-small cell lung cancer: CS-Lung-003 prospective observational registry study.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2024, v. 150, n. 2, p. 1, doi. 10.1007/s00432-024-05618-4
- By:
- Publication type:
- Article
Phase 2 Study of Afatinib Alone or Combined With Bevacizumab in Chemonaive Patients With Advanced Non–Small-Cell Lung Cancer Harboring EGFR Mutations: AfaBev-CS Study Protocol.
- Published in:
- Clinical Lung Cancer, 2019, v. 20, n. 2, p. 134, doi. 10.1016/j.cllc.2018.10.008
- By:
- Publication type:
- Article
Phase 2 Study of Afatinib Alone or Combined With Bevacizumab in Chemonaive Patients With Advanced Non-Small-Cell Lung Cancer Harboring EGFR Mutations: AfaBev-CS Study Protocol.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Three-Arm Randomized Trial of Sodium Alginate for Preventing Radiation-Induced Esophagitis in Locally Advanced Non-Small Cell Lung Cancer Receiving Concurrent Chemoradiotherapy: The OLCSG1401 Study Protocol.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Phase II Study of the EGFR-TKI Rechallenge With Afatinib in Patients With Advanced NSCLC Harboring Sensitive EGFR Mutation Without T790M: Okayama Lung Cancer Study Group Trial OLCSG 1403.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Protocol Design for the Bench to Bed Trial in Alectinib-Refractory Non-Small-Cell Lung Cancer Patients Harboring the EML4-ALK Fusion Gene (ALRIGHT/OLCSG1405).
- Published in:
- 2016
- By:
- Publication type:
- journal article
Facial Erythromelalgia.
- Published in:
- Internal Medicine, 2024, v. 63, n. 9, p. 1327, doi. 10.2169/internalmedicine.2718-23
- By:
- Publication type:
- Article
Retrobulbar Optic Neuritis Induced by Pembrolizumab in a Patient with Lung Adenocarcinoma.
- Published in:
- Internal Medicine, 2021, v. 60, n. 24, p. 3941, doi. 10.2169/internalmedicine.7425-21
- By:
- Publication type:
- Article
Effect of Prophylactic Anti-emetics on Opioid-induced Nausea and Vomiting: A Retrospective Observational Cohort Study.
- Published in:
- In Vivo, 2021, v. 35, n. 3, p. 1737, doi. 10.21873/invivo.12432
- By:
- Publication type:
- Article
Safety of anti‐SARS‐CoV‐2 messenger RNA vaccine in lung cancer patients undergoing anticancer chemotherapy: A multicenter, prospective, observational, patient‐reported outcome study.
- Published in:
- Thoracic Cancer, 2023, v. 14, n. 3, p. 231, doi. 10.1111/1759-7714.14737
- By:
- Publication type:
- Article
Short‐term safety of an anti‐severe acute respiratory syndrome coronavirus 2 messenger RNA vaccine for patients with advanced lung cancer treated with anticancer drugs: A multicenter, prospective, observational study.
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 3, p. 453, doi. 10.1111/1759-7714.14281
- By:
- Publication type:
- Article
Carboplatin, pemetrexed, and pembrolizumab was effective for primary salivary gland‐type lung adenocarcinoma diagnosed due to esophageal stricture: A case report.
- Published in:
- Thoracic Cancer, 2021, v. 12, n. 18, p. 2513, doi. 10.1111/1759-7714.14100
- By:
- Publication type:
- Article
Limited effect of afatinib in a non‐small cell lung cancer patient harboring an epidermal growth factor receptor K860I missense mutation: A case report.
- Published in:
- Thoracic Cancer, 2021, v. 12, n. 11, p. 1770, doi. 10.1111/1759-7714.13941
- By:
- Publication type:
- Article
Novel prospective umbrella‐type lung cancer registry study for clarifying clinical practice patterns: CS‐Lung‐003 study protocol.
- Published in:
- Thoracic Cancer, 2021, v. 12, n. 5, p. 725, doi. 10.1111/1759-7714.13789
- By:
- Publication type:
- Article
A phase II study of S-1 and cisplatin with concurrent thoracic radiotherapy followed by durvalumab for unresectable, locally advanced non-small-cell lung cancer in Japan (SAMURAI study): primary analysis.
- Published in:
- Therapeutic Advances in Medical Oncology, 2022, p. 1, doi. 10.1177/17588359221142786
- By:
- Publication type:
- Article
Prospective analysis of factors precluding the initiation of durvalumab from an interim analysis of a phase II trial of S-1 and cisplatin with concurrent thoracic radiotherapy followed by durvalumab for unresectable, locally advanced non-small cell lung cancer in Japan (SAMURAI study)
- Published in:
- Therapeutic Advances in Medical Oncology, 2022, p. 1, doi. 10.1177/17588359221116603
- By:
- Publication type:
- Article
Incidence of venous thromboembolism in advanced lung cancer and efficacy and safety of direct oral anticoagulants: a multicenter, prospective, observational study (Rising-VTE/NEJ037 study).
- Published in:
- Therapeutic Advances in Medical Oncology, 2022, p. 1, doi. 10.1177/17588359221110171
- By:
- Publication type:
- Article
A phase II study of S-1 and cisplatin with concurrent thoracic radiotherapy followed by durvalumab for unresectable, locally advanced non-small-cell lung cancer in Japan (SAMURAI study).
- Published in:
- Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/1758835921998588
- By:
- Publication type:
- Article
A phase II study of S-1 and cisplatin with concurrent thoracic radiotherapy followed by durvalumab for unresectable, locally advanced non-small-cell lung cancer in Japan (SAMURAI study).
- Published in:
- Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/1758835921998588
- By:
- Publication type:
- Article
Nintedanib can be used safely and effectively for idiopathic pulmonary fibrosis with predicted forced vital capacity ≤ 50%: A multi-center retrospective analysis.
- Published in:
- PLoS ONE, 2020, v. 15, n. 8, p. 1, doi. 10.1371/journal.pone.0236935
- By:
- Publication type:
- Article
Spontaneous regression of multiple solitary plasmacytoma harboring Epstein–Barr virus: a case report and literature review.
- Published in:
- International Journal of Hematology, 2024, v. 120, n. 1, p. 128, doi. 10.1007/s12185-024-03765-5
- By:
- Publication type:
- Article
Paranasal sinus aspergillosis in a patient treated with tirabrutinib.
- Published in:
- 2022
- By:
- Publication type:
- Letter
Identification of risk factors for venous thromboembolism and validation of the Khorana score in patients with advanced lung cancer: based on the multicenter, prospective Rising-VTE/NEJ037 study data.
- Published in:
- International Journal of Clinical Oncology, 2023, v. 28, n. 1, p. 69, doi. 10.1007/s10147-022-02257-y
- By:
- Publication type:
- Article
Pembrolizumab in advanced NSCLC patients with poor performance status and high PD-L1 expression: OLCSG 1801.
- Published in:
- International Journal of Clinical Oncology, 2022, v. 27, n. 7, p. 1139, doi. 10.1007/s10147-022-02164-2
- By:
- Publication type:
- Article
Phase III study of bilayer sustained-release tramadol tablets in patients with cancer pain: a double-blind parallel-group, non-inferiority study with immediate-release tramadol capsules as an active comparator.
- Published in:
- Supportive Care in Cancer, 2024, v. 32, n. 1, p. 1, doi. 10.1007/s00520-023-08242-z
- By:
- Publication type:
- Article
A randomized trial of sodium alginate prevention of esophagitis in LA-NSCLC receiving chemoradiotherapy: OLCSG1401.
- Published in:
- Supportive Care in Cancer, 2021, v. 29, n. 9, p. 5237, doi. 10.1007/s00520-021-06092-1
- By:
- Publication type:
- Article
A new risk-assessment tool for venous thromboembolism in advanced lung cancer: a prospective, observational study.
- Published in:
- 2022
- By:
- Publication type:
- Letter
Antiproteinuric effects of renin-angiotensin inhibitors in lung cancer patients receiving bevacizumab.
- Published in:
- 2018
- By:
- Publication type:
- journal article
A phase II study of topotecan and cisplatin with sequential thoracic radiotherapy in elderly patients with small-cell lung cancer: Okayama Lung Cancer Study Group 0102.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Development of a skin rash within the first week and the therapeutic effect in afatinib monotherapy for EGFR-mutant non-small cell lung cancer (NSCLC): Okayama Lung Cancer Study Group experience.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Cold agglutinin–induced acrocyanosis without hemolytic anemia.
- Published in:
- Annals of Hematology, 2024, v. 103, n. 2, p. 681, doi. 10.1007/s00277-023-05538-2
- By:
- Publication type:
- Article
Trousseau's syndrome in diffuse large B‐cell lymphoma.
- Published in:
- EJHaem, 2024, v. 5, n. 1, p. 271, doi. 10.1002/jha2.837
- By:
- Publication type:
- Article
Transcatheter embolization for idiopathic peripheral pulmonary arterial aneurysm: A case report.
- Published in:
- Clinical Case Reports, 2019, v. 7, n. 5, p. 1021, doi. 10.1002/ccr3.2154
- By:
- Publication type:
- Article
Phase II study of irinotecan and amrubicin in patients with relapsed non-small cell lung cancer: Okayama Lung Cancer Study Group Trial 0402.
- Published in:
- Acta Oncologica, 2012, v. 51, n. 6, p. 768, doi. 10.3109/0284186X.2011.648342
- By:
- Publication type:
- Article
A phase II study of first-line afatinib for patients aged ≥75 years with EGFR mutation-positive advanced non-small cell lung cancer: North East Japan Study Group trial NEJ027.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Long-term survival following concurrent chemoradiotherapy in patients with non-small-cell lung cancer with concomitant brain metastases only.
- Published in:
- International Journal of Clinical Oncology, 2005, v. 10, n. 1, p. 63, doi. 10.1007/s10147-004-0436-y
- By:
- Publication type:
- Article
Sex difference in the influence of smoking status on the responsiveness to gefitinib monotherapy in adenocarcinoma of the lung: Okayama Lung Cancer Study Group experience.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2009, v. 135, n. 1, p. 117, doi. 10.1007/s00432-008-0431-1
- By:
- Publication type:
- Article
Benefit of prednisolone alone in nodal peripheral T-cell lymphoma with T follicular helper phenotype.
- Published in:
- Journal of Clinical & Experimental Hematopathology, 2023, v. 63, n. 1, p. 37, doi. 10.3960/jslrt.22038
- By:
- Publication type:
- Article
A phase II trial of cisplatin and irinotecan alternating with doxorubicin, cyclophosphamide and etoposide in previously untreated patients with extensive-disease small-cell lung cancer.
- Published in:
- 2007
- By:
- Publication type:
- journal article
A phase II trial of cisplatin and irinotecan alternating with doxorubicin, cyclophosphamide and etoposide in previously untreated patients with extensive-disease small-cell lung cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2007, v. 60, n. 1, p. 1, doi. 10.1007/s00280-006-0336-0
- By:
- Publication type:
- Article
Survival of chemo-naïve patients with EGFR mutation-positive advanced non-small cell lung cancer after treatment with afatinib and bevacizumab: updates from the Okayama Lung Cancer Study Group Trial 1404.
- Published in:
- Japanese Journal of Clinical Oncology, 2021, v. 51, n. 8, p. 1269, doi. 10.1093/jjco/hyab084
- By:
- Publication type:
- Article
Multicenter phase II study on cisplatin, pemetrexed, and bevacizumab followed by maintenance with pemetrexed and bevacizumab for patients with advanced or recurrent nonsquamous non-small cell lung cancer: MAP study.
- Published in:
- 2018
- By:
- Publication type:
- journal article